Developer docs
API playgroundTry for free, no card

Search company profiles

Beckley Waves

Full company profile

uuid00031aa

Namestring
Beckley Waves
Legal namestring
Beckley Waves
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Beckley Waves is a private venture studio and holding company founded in 2020 by Amanda Feilding, Rock Feilding-Mellen, and Daniel Love to build the care delivery infrastructure for psychedelic-assisted therapies. Operating as a holding company, it co-founds, incubates, and invests in companies that address how psychedelic and adjacent therapies reach people safely, effectively, and at scale — a structural gap left by capital concentrated in research and drug development. Its portfolio spans the full care continuum: Beckley Clinical (interventional psychiatry care delivery and reimbursement), Beckley Retreats (legal psychedelic wellbeing programs), Beckley Academy (practitioner training and certification), Lumenate (digital at-home wellbeing app using sensory entrainment), Homecoming (integration support platform for clinics and retreats), and Sanarte (concierge family-centered mental health). The company also owns and operates The Trip Report, a newsletter and podcast covering psychedelic business, science, and policy.

Commercially, Beckley Waves generates returns through equity ownership in portfolio companies rather than direct product sales. Revenue mechanics span cash-pay clinical services (Beckley Clinical), retreat programs (Beckley Retreats), subscriptions and consumer transactions in digital wellness (Lumenate), training program fees (Beckley Academy), and SaaS-style tooling for practitioners (Homecoming). The company participates in a broader Beckley ecosystem that includes the Beckley Foundation (research and policy) and Beckley Psytech, the drug development pillar that merged into Atai Beckley Inc in November 2025. Beckley Waves raised a $3.3 million seed round in September 2023 from 1440 Foundation, Bridge Builders Collaborative, Evolve Ventures, FJ Labs, Samberg Foundation, and Satori Capital, and acquired Nue Life Health in October 2023, adding more than 100,000 cumulative ketamine experiences to the platform.

Short descriptiontext

Beckley Waves is a psychedelic-focused venture studio that co-founds, incubates, and invests in companies building care delivery infrastructure for psychedelic-assisted therapies, spanning clinical services, retreats, practitioner training, digital wellbeing, and mental health support globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBeckley, United Kingdom
HQ citystring
Beckley
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
venture studio services, psychedelic therapy infrastructure, behavioral health innovation, psychiatric care delivery, mental health investment
Industry5 codes
PRIMARYHLAFACAN
Peer Support, Recovery Coaching & Sober Living Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHSADAJAF
Meditation Retreats, Workshops & Immersive Programs
SECONDARYTHAGAMAI
Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work)
Travel & Hospitality/Lodging & Accommodation/Wellness, Spa & Health Retreats
SECONDARYTHAJAHAH
Mindfulness & Mental Wellbeing Experiences (Stress Management, Sleep Retreats, Coaching)
Travel & Hospitality/Tours, Attractions & Experiences/Wellness & Spa Experiences (Retreats, Thermal Baths, Yoga)
SECONDARYEDALAFAO
Recreation Therapy, Stress Management & Mindfulness Programs
Education/Student Services & Campus Operations/Student Health, Counseling & Wellness Services
NAICS code1 code
  • Offices of Physicians, Mental Health Specialists621112
SIC code1 code
  • Services-Health Services8000
Product category
Psychedelic Care Venture Studio
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Studio and Investment Returns
TypeSubscription Recurring
Description

Beckley Waves operates as a venture studio that generates returns through equity ownership in portfolio companies it co-founds and incubates. The company invests in early-stage companies developing infrastructure and services for psychedelic therapies.

globenewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1The Trip Report
Description

Newsletter and podcast covering the business, science, and policy developments of the evolving psychedelic field

beckleywaves.com
+3 more records
Core offering1 text field

Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds, incubates, or invests in companies building the operational infrastructure for safe, legal, and effective delivery of psychedelic-assisted therapies. Its portfolio covers clinical interventional psychiatry (Beckley Clinical), guided psychedelic wellbeing programs (Beckley Retreats), practitioner training (Beckley Academy), digital at-home neuro-entrainment experiences (Lumenate), therapist/clinic integration software (Homecoming), and concierge family-centered mental health (Sanarte). The company also publishes The Trip Report newsletter and podcast covering psychedelic business, science, and policy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 100,000+ ketamine experiences facilitated through acquired portfolio company Nue Life Health
Product overview1 text field

Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds and invests in companies to build the operational infrastructure for the global psychedelic ecosystem. The portfolio includes Beckley Clinical (interventional psychiatry care delivery), Beckley Retreats (legal psychedelic wellbeing programs), Beckley Academy (professional training for practitioners), Lumenate (digital at-home wellness platform), Homecoming (integration support platform), Sanarte (concierge family-centered mental health), and The Trip Report (industry newsletter and podcast).

Product and service6 records
1Beckley Clinical
CategoryInterventional psychiatry and behavioral health care delivery
Description

Behavioral health innovation company delivering evidence-based, personalized treatment solutions for hard-to-treat conditions, focused on building care delivery and reimbursement models for interventional psychiatry in the United States.

2Beckley Retreats
CategoryGuided psychedelic wellbeing and retreat programs
Description

Provider of legal psychedelic wellbeing programs offering guided psychedelic experiences in safe, lawful settings, blending modern science with indigenous practices to support health and human flourishing beyond traditional medical models.

3Beckley Academy
CategoryProfessional education and certification
Description

World-class training program and professional network educating, training, and certifying therapists, practitioners, and facilitators to deliver safe, ethical, and legal psychedelic-assisted therapies.

4Lumenate
CategoryDigital wellness and at-home neuro-entrainment platform
Description

Digital platform offering accessible at-home experiences for meditation, insight, and expanded awareness via a smartphone-enabled app using scientifically calibrated flashing light (sensory entrainment) to guide users into neural states optimized for subconscious exploration.

5Homecoming
CategoryTherapist and clinic integration software (SaaS)
Description

SaaS platform partnering with psychedelic therapists, clinics, and retreats to support clients before, between, and after sessions through personalized tasks, guides, daily check-ins, data analytics, and a practitioner growth/patient-referral network.

6Sanarte
CategoryConcierge mental health and family-centered care
Description

Concierge mental health service championing a wellness approach emphasizing relationships and family-centered care, delivering comprehensive integrated specialist services with holistic, evidence-based practices for enduring positive outcomes.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Non-profit, non-governmental organization and think tank that initiates, funds, and supports scientific research driving adoption of evidence-based psychedelic therapies and drug-policy reforms globally. Sister organization with shared belief in transformative potential of psychedelics and common goal of ethical leadership in the psychedelic ecosystem.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Drug development company advancing psychedelic medicines to unlock therapeutic potential at scale. Merged into Atai Beckley Inc in November 2025. Part of the broader Beckley ecosystem focused on drug development complementing Beckley Waves' care delivery focus.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company leading in behavioral health innovation, committed to delivering transformative health outcomes through evidence-based, personalized treatment solutions for hard-to-treat conditions. Focus on care delivery and reimbursement for interventional psychiatry.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company providing legal psychedelic wellbeing programs with world-class facilitators blending modern science and indigenous practices for guided psychedelic experiences in safe, lawful settings.

5Beckley Academy
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company providing world-class training program and professional network for therapists, practitioners, and facilitators working to meet growing demand for safe, ethical, legal psychedelic-assisted therapies.

beckleywaves.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company offering digital platform with smartphone-enabled app using sensory entrainment through flashing light to activate neurons for subconscious exploration, meditation, and expanded awareness.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company partnering with psychedelic therapists, clinics, and retreats to support clients before, between, and after sessions with personalized tasks, guides, daily check-ins, and practitioner growth tools.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company providing pioneering concierge mental health services with family-centered care approach, integrated specialist teams, and holistic evidence-based practices for enduring positive outcomes.

9Nue Life Health
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Acquired company that had facilitated over 100,000 ketamine experiences. Represents Beckley Waves' acquisition strategy for building at-home ketamine therapy capabilities as market shifts from brick-and-mortar clinics to scalable, technology-enabled home-based care models.

cbhd.news
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1ATAI Life Sciences
TypeBroad incumbent
Description

Public psychedelic mental-health platform and parent of Atai Beckley Inc. Directly comparable as a sister entity in the Beckley ecosystem, with overlapping psychedelic therapy focus but a drug-development (rather than care-delivery) orientation.

TypeBroad incumbent
Description

Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Comparable as a leading investor in psychedelic-assisted therapy infrastructure, though focused on drug development rather than care-delivery models.

TypeDirect peer
Description

Public Canadian company operating psychedelic therapy clinics and a research division. Closely comparable to Beckley Waves as a care-delivery operator with clinical, wellness, and research arms spanning ketamine and psilocybin-assisted therapy.

4Field Trip Health (defunct)
TypeDirect peer
Description

Operated psychedelic-assisted therapy clinics across North America and Europe before winding down. Most directly comparable historical peer to Beckley Clinical/Beckley Retreats for the clinic-and-wellness care-delivery model.

TypeEmerging player
Description

Public clinical-stage company developing mebufotenin (5-MeO-DMT) therapies for depression. Comparable as a psychedelic-focused peer, though narrower drug-development orientation versus Beckley Waves' diversified studio approach.

TypeEmerging player
Description

Public clinical-stage psychedelic company developing psilocybin analogs and deuterated DMT. Comparable as a peer pursuing psychedelic therapy development with adjacent digital-support offerings (like Beckley Waves' Homecoming).

7Novamind (formerly Mydecine)
TypeDirect peer
Description

Public psychedelic mental-health company operating ketamine-assisted therapy clinics and research sites. Comparable as a peer in the psychedelic clinic and care-delivery space, particularly to Beckley Clinical.

TypeEmerging player
Description

Clinical-stage biotech developing non-hallucinogenic psychedelic-inspired medicines. Comparable as a peer addressing mental-health via psychedelic-adjacent approaches, though Delix is purely drug-development.

9Beehive Healthcare / Ketamine Clinic peers (e.g., Klarity, Joyous)
TypeRegional player
Description

At-home ketamine therapy platforms with similar care-delivery models to Beckley's inherited Nue Life business. Comparable as direct peers in the home-based ketamine treatment market.

10MindMed
TypeBroad incumbent
Description

Public clinical-stage psychedelic medicine company developing LSD and MDMA-based therapies. Comparable as a peer in the psychedelic mental-health ecosystem with parallel drug-development and digital-health ambitions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Beckley Waves

Psychedelic Care Venture Studiobeckleywaves.com

Beckley Waves is a psychedelic-focused venture studio that co-founds, incubates, and invests in companies building care delivery infrastructure for psychedelic-assisted therapies, spanning clinical services, retreats, practitioner training, digital wellbeing, and mental health support globally.

What Beckley Waves does

Beckley Waves is a private venture studio and holding company founded in 2020 by Amanda Feilding, Rock Feilding-Mellen, and Daniel Love to build the care delivery infrastructure for psychedelic-assisted therapies. Operating as a holding company, it co-founds, incubates, and invests in companies that address how psychedelic and adjacent therapies reach people safely, effectively, and at scale — a structural gap left by capital concentrated in research and drug development. Its portfolio spans the full care continuum: Beckley Clinical (interventional psychiatry care delivery and reimbursement), Beckley Retreats (legal psychedelic wellbeing programs), Beckley Academy (practitioner training and certification), Lumenate (digital at-home wellbeing app using sensory entrainment), Homecoming (integration support platform for clinics and retreats), and Sanarte (concierge family-centered mental health). The company also owns and operates The Trip Report, a newsletter and podcast covering psychedelic business, science, and policy.

Commercially, Beckley Waves generates returns through equity ownership in portfolio companies rather than direct product sales. Revenue mechanics span cash-pay clinical services (Beckley Clinical), retreat programs (Beckley Retreats), subscriptions and consumer transactions in digital wellness (Lumenate), training program fees (Beckley Academy), and SaaS-style tooling for practitioners (Homecoming). The company participates in a broader Beckley ecosystem that includes the Beckley Foundation (research and policy) and Beckley Psytech, the drug development pillar that merged into Atai Beckley Inc in November 2025. Beckley Waves raised a $3.3 million seed round in September 2023 from 1440 Foundation, Bridge Builders Collaborative, Evolve Ventures, FJ Labs, Samberg Foundation, and Satori Capital, and acquired Nue Life Health in October 2023, adding more than 100,000 cumulative ketamine experiences to the platform.

Beckley Waves firmographics

Firmographics
Name
Beckley Waves
Legal name
Beckley Waves
Website
https://beckleywaves.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Beckley Waves is a psychedelic-focused venture studio that co-founds, incubates, and invests in companies building care delivery infrastructure for psychedelic-assisted therapies, spanning clinical services, retreats, practitioner training, digital wellbeing, and mental health support globally.
Ownership category
akta.pro rank

Beckley Waves industry classification

Industry
Product category
Psychedelic Care Venture Studio
NAICS
Offices of Physicians, Mental Health Specialists (621112)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFACAN
Peer Support, Recovery Coaching & Sober Living Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHSADAJAF
Meditation Retreats, Workshops & Immersive Programs
SECONDARYTHAGAMAI
Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work)
Travel & Hospitality/Lodging & Accommodation/Wellness, Spa & Health Retreats
SECONDARYTHAJAHAH
Mindfulness & Mental Wellbeing Experiences (Stress Management, Sleep Retreats, Coaching)
Travel & Hospitality/Tours, Attractions & Experiences/Wellness & Spa Experiences (Retreats, Thermal Baths, Yoga)
SECONDARYEDALAFAO
Recreation Therapy, Stress Management & Mindfulness Programs
Education/Student Services & Campus Operations/Student Health, Counseling & Wellness Services

Keywords

  • Venture studio services
  • Psychedelic therapy infrastructure
  • Behavioral health innovation
  • Psychiatric care delivery
  • Mental health investment

Where Beckley Waves is headquartered

Location

Headquarters

HQ city
Beckley
HQ country
United Kingdom
HQ region
Europe

Markets served

Beckley Waves business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Venture Studio and Investment Returns: Beckley Waves operates as a venture studio that generates returns through equity ownership in portfolio companies it co-founds and incubates. The company invests in early-stage companies developing infrastructure and services for psychedelic therapies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Beckley Waves product offering

Product offering

Core offering

Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds, incubates, or invests in companies building the operational infrastructure for safe, legal, and effective delivery of psychedelic-assisted therapies. Its portfolio covers clinical interventional psychiatry (Beckley Clinical), guided psychedelic wellbeing programs (Beckley Retreats), practitioner training (Beckley Academy), digital at-home neuro-entrainment experiences (Lumenate), therapist/clinic integration software (Homecoming), and concierge family-centered mental health (Sanarte). The company also publishes The Trip Report newsletter and podcast covering psychedelic business, science, and policy.

Product overview

Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds and invests in companies to build the operational infrastructure for the global psychedelic ecosystem. The portfolio includes Beckley Clinical (interventional psychiatry care delivery), Beckley Retreats (legal psychedelic wellbeing programs), Beckley Academy (professional training for practitioners), Lumenate (digital at-home wellness platform), Homecoming (integration support platform), Sanarte (concierge family-centered mental health), and The Trip Report (industry newsletter and podcast).

Differentiator

Problem solved

Functional benefit

Brands

  • The Trip Report: Newsletter and podcast covering the business, science, and policy developments of the evolving psychedelic field
  • Beckley Clinical
  • Beckley Retreats
  • Beckley Academy

Products and services

  • Beckley Clinical Behavioral health innovation company delivering evidence-based, personalized treatment solutions for hard-to-treat conditions, focused on building care delivery and reimbursement models for interventional psychiatry in the United States.
  • Beckley Retreats Provider of legal psychedelic wellbeing programs offering guided psychedelic experiences in safe, lawful settings, blending modern science with indigenous practices to support health and human flourishing beyond traditional medical models.
  • Beckley Academy World-class training program and professional network educating, training, and certifying therapists, practitioners, and facilitators to deliver safe, ethical, and legal psychedelic-assisted therapies.
  • Lumenate Digital platform offering accessible at-home experiences for meditation, insight, and expanded awareness via a smartphone-enabled app using scientifically calibrated flashing light (sensory entrainment) to guide users into neural states optimized for subconscious exploration.
  • Homecoming SaaS platform partnering with psychedelic therapists, clinics, and retreats to support clients before, between, and after sessions through personalized tasks, guides, daily check-ins, data analytics, and a practitioner growth/patient-referral network.
  • Sanarte Concierge mental health service championing a wellness approach emphasizing relationships and family-centered care, delivering comprehensive integrated specialist services with holistic, evidence-based practices for enduring positive outcomes.

Quantifiable outcome

  • 100,000+ ketamine experiences facilitated through acquired portfolio company Nue Life Health

Companies that use Beckley Waves

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Beckley Waves technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Beckley Waves partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Beckley FoundationcoreStrategic or Co-development Partner · 1 January 2020Non-profit, non-governmental organization and think tank that initiates, funds, and supports scientific research driving adoption of evidence-based psychedelic therapies and drug-policy reforms globally. Sister organization with shared belief in transformative potential of psychedelics and common goal of ethical leadership in the psychedelic ecosystem.
  • Beckley Psytech (now Atai Beckley Inc)coreStrategic or Co-development Partner · 1 January 2020Drug development company advancing psychedelic medicines to unlock therapeutic potential at scale. Merged into Atai Beckley Inc in November 2025. Part of the broader Beckley ecosystem focused on drug development complementing Beckley Waves' care delivery focus.
  • Beckley ClinicalcoreStrategic or Co-development PartnerPortfolio company leading in behavioral health innovation, committed to delivering transformative health outcomes through evidence-based, personalized treatment solutions for hard-to-treat conditions. Focus on care delivery and reimbursement for interventional psychiatry.
  • Beckley RetreatscoreStrategic or Co-development PartnerPortfolio company providing legal psychedelic wellbeing programs with world-class facilitators blending modern science and indigenous practices for guided psychedelic experiences in safe, lawful settings.
  • Beckley AcademycoreStrategic or Co-development PartnerPortfolio company providing world-class training program and professional network for therapists, practitioners, and facilitators working to meet growing demand for safe, ethical, legal psychedelic-assisted therapies.
  • LumenateminorStrategic or Co-development PartnerPortfolio company offering digital platform with smartphone-enabled app using sensory entrainment through flashing light to activate neurons for subconscious exploration, meditation, and expanded awareness.
  • HomecomingminorStrategic or Co-development PartnerPortfolio company partnering with psychedelic therapists, clinics, and retreats to support clients before, between, and after sessions with personalized tasks, guides, daily check-ins, and practitioner growth tools.
  • SanarteminorStrategic or Co-development PartnerPortfolio company providing pioneering concierge mental health services with family-centered care approach, integrated specialist teams, and holistic evidence-based practices for enduring positive outcomes.
  • Nue Life HealthminorStrategic or Co-development PartnerAcquired company that had facilitated over 100,000 ketamine experiences. Represents Beckley Waves' acquisition strategy for building at-home ketamine therapy capabilities as market shifts from brick-and-mortar clinics to scalable, technology-enabled home-based care models.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Beckley Waves competitors and assessment

Company assessment

Broad incumbents

  • ATAI Life Sciences: Public psychedelic mental-health platform and parent of Atai Beckley Inc. Directly comparable as a sister entity in the Beckley ecosystem, with overlapping psychedelic therapy focus but a drug-development (rather than care-delivery) orientation.
  • Compass Pathways: Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Comparable as a leading investor in psychedelic-assisted therapy infrastructure, though focused on drug development rather than care-delivery models.
  • MindMed: Public clinical-stage psychedelic medicine company developing LSD and MDMA-based therapies. Comparable as a peer in the psychedelic mental-health ecosystem with parallel drug-development and digital-health ambitions.

Direct peers

  • Numinus Wellness: Public Canadian company operating psychedelic therapy clinics and a research division. Closely comparable to Beckley Waves as a care-delivery operator with clinical, wellness, and research arms spanning ketamine and psilocybin-assisted therapy.
  • Field Trip Health (defunct): Operated psychedelic-assisted therapy clinics across North America and Europe before winding down. Most directly comparable historical peer to Beckley Clinical/Beckley Retreats for the clinic-and-wellness care-delivery model.
  • Novamind (formerly Mydecine): Public psychedelic mental-health company operating ketamine-assisted therapy clinics and research sites. Comparable as a peer in the psychedelic clinic and care-delivery space, particularly to Beckley Clinical.

Emerging players

  • GH Research: Public clinical-stage company developing mebufotenin (5-MeO-DMT) therapies for depression. Comparable as a psychedelic-focused peer, though narrower drug-development orientation versus Beckley Waves' diversified studio approach.
  • Cybin Inc: Public clinical-stage psychedelic company developing psilocybin analogs and deuterated DMT. Comparable as a peer pursuing psychedelic therapy development with adjacent digital-support offerings (like Beckley Waves' Homecoming).
  • Delix Therapeutics: Clinical-stage biotech developing non-hallucinogenic psychedelic-inspired medicines. Comparable as a peer addressing mental-health via psychedelic-adjacent approaches, though Delix is purely drug-development.

Regional players

  • Beehive Healthcare / Ketamine Clinic peers (e.g., Klarity, Joyous): At-home ketamine therapy platforms with similar care-delivery models to Beckley's inherited Nue Life business. Comparable as direct peers in the home-based ketamine treatment market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Beckley Waves social profiles

Digital presence

Beckley Waves financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Beckley Waves leadership team

Management profile

Number of profiles

Profiles5 records

Beckley Waves subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Beckley Waves funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Beckley Waves M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beckley Waves

What does Beckley Waves do?

Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds, incubates, or invests in companies building the operational infrastructure for safe, legal, and effective delivery of psychedelic-assisted therapies. Its portfolio covers clinical interventional psychiatry (Beckley Clinical), guided psychedelic wellbeing programs (Beckley Retreats), practitioner training (Beckley Academy), digital at-home neuro-entrainment experiences (Lumenate), therapist/clinic integration software (Homecoming), and concierge family-centered mental health (Sanarte). The company also publishes The Trip Report newsletter and podcast covering psychedelic business, science, and policy.

Is Beckley Waves a public or private company?

Beckley Waves is a private company. It is classified as venture growth investor backed and is currently operating.

When was Beckley Waves founded?

Beckley Waves was founded in 2020. It employs 1 to 10 people.

Where is Beckley Waves based?

Beckley Waves is headquartered in Beckley, United Kingdom, in the Europe region.

How does Beckley Waves make money?

One revenue line is on record: venture Studio and Investment Returns.

Who are Beckley Waves's main competitors?

Broad incumbents on record are ATAI Life Sciences, Compass Pathways and MindMed. Direct peers are Numinus Wellness, Field Trip Health (defunct) and Novamind (formerly Mydecine). Emerging players are GH Research, Cybin Inc and Delix Therapeutics. Beehive Healthcare / Ketamine Clinic peers (e.g., Klarity, Joyous) is listed as a regional player.

Does Beckley Waves have an API?

No public API is recorded for Beckley Waves.

What industry is Beckley Waves in?

Beckley Waves's product category is Psychedelic Care Venture Studio. Its primary akta.pro industry code is HLAFACAN, Peer Support, Recovery Coaching & Sober Living Services, with a secondary code of HSADAJAF, Meditation Retreats, Workshops & Immersive Programs. Its NAICS code is 621112 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CbhdAt-Home Ketamine Therapy: Trends & 2026 OutlookThe at-home ketamine therapy market in the Southern United States is undergoing a structural shift from capital-intensive brick-and-mortar clinics to scalable, technology-enabled home-based care models, driven by regulatory extensions, consumer demand for affordability, and telemedicine infrastructure maturity. Key strategic transactions highlight this migration, including Beckley Waves' acquisition of Nue Life Health (which had facilitated over 100,000 ketamine experiences) and ongoing market consolidation as smaller brick-and-mortar chains struggle against cheaper home-based alternatives. The industry's fate hinges on the DEA's 2026 telemedicine prescribing guidelines, with major players aggressively scaling infrastructure to establish market share before permanent rules are codified.GlobeNewswireBeckley Waves Celebrates a Year of Milestones, Including $3.3 Million in New Funding, 200 Retreat Participants, the Inaugural Cohort of Therapist Training, and the Acquisition of Ketamine Therapy ProvBeckley Waves celebrated 2023 milestones, including a $3.3 million funding round and the acquisition of ketamine therapy provider Nue Life. The venture studio also expanded its retreat and training programs, with Beckley Retreats planning women-only retreats in Jamaica and the Netherlands in 2024.BhbusinessPsychedelic Venture Studio Beckley Waves Acquires Ketamine Provider Nue LifeBeckley Waves acquired digital ketamine-assisted therapy provider Nue Life, which treats patients across 23 states. Nue Life's in-home KAT costs $1,000–$1,400, versus $4,500–$6,000 for clinic-based care. The company plans slow, sustainable growth and aims to improve payer reimbursement.GlobeNewswireBeckley Waves Acquires Nue LifeBeckley Waves acquired Nue Life, a ketamine-assisted therapy provider, to expand its psychedelic care infrastructure. Nue Life has treated over 10,000 patients across 23 US states since 2021. The acquisition adds to Beckley Waves' portfolio, which includes Beckley Retreats and Beckley Academy.FinSMEsBeckley Waves Raises $3.3M Funding RoundBeckley Waves, a London-based venture studio, raised $3.3M in funding from backers including the Joe & Sandy Samberg Foundation and Satori Neuro. The funds will support building and investing in startups for safe, legal psychedelic therapy access. The studio co-founded Beckley Retreats, Beckley Academy, and The Trip Report.GlobeNewswireBeckley Waves Raises $3.3 Million Funding Round to Expand Safe and Legal Access To Psychedelic TherapiesBeckley Waves closed a $3.3 million funding round, exceeding its target by 10%. Investors include the Joe & Sandy Samberg Foundation, Satori Neuro, and others. The funds will support building and investing in startups for safe, legal psychedelic therapy access.GlobeNewswireBeckley Waves Raises $3.3 Million Funding Round to Expand Safe and Legal Access To Psychedelic TherapiesBeckley Waves announced the completion of its $3.3 million funding round, exceeding its target by 10%. This funding will support the company's initiative to expand safe and legal access to psychedelic therapies and invest in emerging startups within the psychedelic ecosystem. Beckley Waves has previously co-founded critical companies in the space, setting the stage for future growth and innovation in mental health treatment.GlobeNewswireThe Trip Report by Beckley Waves Launches The Trip Report PodcastThe Trip Report by Beckley Waves launched a podcast featuring interviews with psychedelic industry leaders. The newsletter's readership grew 100% in the past year, and investment in psychedelic businesses has surpassed $2 billion. Season one guests include Amanda Feilding and Dr. Amy Kruse.GlobeNewswireBeckley Waves Establishes Ethics Council to Guide Industry Standards and Best Practices During Inaugural Summit of The World’s Leaders in PsychedelicsBeckley Waves announced a new Ethics Council to guide industry standards in the psychedelics sector. The council includes experts such as Paul Stamets, Rick Doblin, and Amanda Feilding, and will address sustainable practices, equitable access, and ethical IP. More leaders will be invited to join as the council develops.PR NewswireMillions to gain access to Psychedelic Psychotherapy in bid to fight pandemic induced depression and anxietyJourney Clinical launched a new service on June 17, 2021, enabling self-employed psychotherapists and independent practices to offer ketamine-assisted psychotherapy (KAP) to patients, expanding access beyond chain clinics to an estimated 100 million Americans dealing with depression and anxiety. The company completed its pre-seed funding round in March 2021 with investments from Neo Kuma Ventures, PsyMed Ventures, and Beckley Waves, and is opening its seed round this month. The launch addresses a critical gap in mental health treatment amid a pandemic-exacerbated crisis, with 53% of Americans reportedly ready to embrace psychedelic therapies.